ATE400271T1 - Aryl-pyridinderivate als 11-beta-hsd1-hemmer - Google Patents
Aryl-pyridinderivate als 11-beta-hsd1-hemmerInfo
- Publication number
- ATE400271T1 ATE400271T1 AT05776709T AT05776709T ATE400271T1 AT E400271 T1 ATE400271 T1 AT E400271T1 AT 05776709 T AT05776709 T AT 05776709T AT 05776709 T AT05776709 T AT 05776709T AT E400271 T1 ATE400271 T1 AT E400271T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- aryl
- pyridine derivatives
- hsd1 inhibitors
- hsd1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04103639 | 2004-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE400271T1 true ATE400271T1 (de) | 2008-07-15 |
Family
ID=35427898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05776709T ATE400271T1 (de) | 2004-07-28 | 2005-07-20 | Aryl-pyridinderivate als 11-beta-hsd1-hemmer |
Country Status (27)
Country | Link |
---|---|
US (2) | US7528159B2 (de) |
EP (1) | EP1789041B1 (de) |
JP (1) | JP4690402B2 (de) |
KR (1) | KR100926842B1 (de) |
CN (1) | CN100589803C (de) |
AR (1) | AR049739A1 (de) |
AT (1) | ATE400271T1 (de) |
AU (1) | AU2005266531B2 (de) |
BR (1) | BRPI0513864A (de) |
CA (1) | CA2574875C (de) |
DE (1) | DE602005008079D1 (de) |
DK (1) | DK1789041T3 (de) |
ES (1) | ES2309789T3 (de) |
HK (1) | HK1105592A1 (de) |
HR (1) | HRP20080477T3 (de) |
IL (1) | IL180481A (de) |
MX (1) | MX2007000789A (de) |
MY (1) | MY138941A (de) |
NO (1) | NO20070458L (de) |
NZ (1) | NZ552398A (de) |
PL (1) | PL1789041T3 (de) |
PT (1) | PT1789041E (de) |
RU (1) | RU2374239C2 (de) |
SI (1) | SI1789041T1 (de) |
TW (1) | TW200608972A (de) |
WO (1) | WO2006010546A2 (de) |
ZA (1) | ZA200700181B (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006010546A2 (en) * | 2004-07-28 | 2006-02-02 | F. Hoffman-La Roche Ag | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
WO2006106423A2 (en) * | 2005-04-07 | 2006-10-12 | Pfizer Inc. | Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
BRPI0707537A2 (pt) * | 2006-02-07 | 2011-05-03 | Wyeth Corp | inibidores de 11-beta hsd1 |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
US20100022572A1 (en) | 2008-07-18 | 2010-01-28 | Kowa Company, Ltd. | Novel spiro compound and medicine comprising the same |
US8236789B2 (en) | 2008-08-29 | 2012-08-07 | Kowa Company, Ltd. | 1-adamantyl azetidin-2-one derivatives and drugs containing same |
TW201022210A (en) | 2008-10-29 | 2010-06-16 | Kowa Co | 1,2-diazetidin-3-one derivatives and drugs containing same |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
MA33358B1 (fr) | 2009-05-15 | 2012-06-01 | Novartis Ag | Arylpyridine en tant qu'inhibiteurs de l'aldostérone synthase |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
US8871208B2 (en) * | 2009-12-04 | 2014-10-28 | Abbvie Inc. | 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
HUE031585T2 (en) * | 2011-03-16 | 2017-07-28 | Mitsubishi Tanabe Pharma Corp | Sulfonamide Compounds with TRPM8 Antagonist Activity |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
KR102083041B1 (ko) | 2012-02-22 | 2020-05-27 | 샌포드 번햄 프레비즈 메디컬 디스커버리 인스티튜트 | 술폰아미드 화합물 및 tnap 억제제로서 용도 |
KR20150092162A (ko) * | 2012-12-10 | 2015-08-12 | 에프. 호프만-라 로슈 아게 | RORc 조절인자로서 벤질 설폰아미드 유도체 |
CN105175323B (zh) * | 2015-09-16 | 2017-12-22 | 浙江海翔药业股份有限公司 | 一种制备2‑(4‑乙酰胺基苯磺酰基)胺基吡啶的方法 |
AU2019213484A1 (en) * | 2018-02-05 | 2020-07-02 | Centre National De La Recherche Scientifique | Compounds and compositions for the treatment of pain |
ES2910071T3 (es) | 2018-03-08 | 2022-05-11 | Incyte Corp | Compuestos de aminopirazina diol como inhibidores de PI3K-Y |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
KR102418518B1 (ko) * | 2020-08-05 | 2022-07-07 | 성균관대학교산학협력단 | 설퍼 일라이드를 이용한 n-헤테로고리의 선택적 알킬화 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2159938A1 (en) * | 1994-10-07 | 1996-04-08 | Hiroaki Yanagisawa | Oxime derivatives, their preparation and their therapeutic use |
WO2003043999A1 (en) | 2001-11-22 | 2003-05-30 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
AU2002353716A1 (en) * | 2001-11-22 | 2003-06-10 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
KR20050025189A (ko) * | 2002-07-27 | 2005-03-11 | 아스트라제네카 아베 | 화학 화합물 |
WO2006010546A2 (en) * | 2004-07-28 | 2006-02-02 | F. Hoffman-La Roche Ag | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
-
2005
- 2005-07-20 WO PCT/EP2005/007894 patent/WO2006010546A2/en active IP Right Grant
- 2005-07-20 KR KR1020077002036A patent/KR100926842B1/ko not_active IP Right Cessation
- 2005-07-20 DK DK05776709T patent/DK1789041T3/da active
- 2005-07-20 BR BRPI0513864-7A patent/BRPI0513864A/pt not_active IP Right Cessation
- 2005-07-20 NZ NZ552398A patent/NZ552398A/en not_active IP Right Cessation
- 2005-07-20 PL PL05776709T patent/PL1789041T3/pl unknown
- 2005-07-20 CA CA2574875A patent/CA2574875C/en not_active Expired - Fee Related
- 2005-07-20 RU RU2007107189/04A patent/RU2374239C2/ru not_active IP Right Cessation
- 2005-07-20 EP EP05776709A patent/EP1789041B1/de active Active
- 2005-07-20 AT AT05776709T patent/ATE400271T1/de active
- 2005-07-20 CN CN200580025005A patent/CN100589803C/zh not_active Expired - Fee Related
- 2005-07-20 JP JP2007522984A patent/JP4690402B2/ja not_active Expired - Fee Related
- 2005-07-20 SI SI200530343T patent/SI1789041T1/sl unknown
- 2005-07-20 PT PT05776709T patent/PT1789041E/pt unknown
- 2005-07-20 DE DE602005008079T patent/DE602005008079D1/de active Active
- 2005-07-20 AU AU2005266531A patent/AU2005266531B2/en not_active Ceased
- 2005-07-20 MX MX2007000789A patent/MX2007000789A/es active IP Right Grant
- 2005-07-20 ES ES05776709T patent/ES2309789T3/es active Active
- 2005-07-25 TW TW094125138A patent/TW200608972A/zh unknown
- 2005-07-26 AR ARP050103098A patent/AR049739A1/es unknown
- 2005-07-26 MY MYPI20053431A patent/MY138941A/en unknown
- 2005-07-26 US US11/189,598 patent/US7528159B2/en not_active Expired - Fee Related
-
2007
- 2007-01-01 IL IL180481A patent/IL180481A/en not_active IP Right Cessation
- 2007-01-05 ZA ZA200700181A patent/ZA200700181B/xx unknown
- 2007-01-24 NO NO20070458A patent/NO20070458L/no not_active Application Discontinuation
- 2007-12-20 HK HK07114003.9A patent/HK1105592A1/xx not_active IP Right Cessation
-
2008
- 2008-09-26 HR HR20080477T patent/HRP20080477T3/xx unknown
-
2009
- 2009-02-17 US US12/372,244 patent/US8211913B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
ATE452631T1 (de) | N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer | |
ATE540936T1 (de) | Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer | |
ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
ATE446090T1 (de) | Thiadiazolidinone als gsk3-inhibitoren | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
ATE452635T1 (de) | Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer | |
ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
ATE540935T1 (de) | Chinazolinderivate | |
ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
ATE501138T1 (de) | Thiophenderivate als chk-1-inhibitoren | |
ATE521607T1 (de) | Piperidinderivate als renin-inhibitoren | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
ATE478064T1 (de) | Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate | |
ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
ATE531705T1 (de) | Substituierte 2-chinolyloxazole geeignet als pde4 inhibitoren | |
ATE462692T1 (de) | 3-amino-1-arylpropyl-indole als monoamin- wiederaufnahmehemmer | |
DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
ATE467623T1 (de) | Diazepan-acetamidderivate als selektive 11-hsd1- hemmer | |
ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1789041 Country of ref document: EP |